RegenMed Systems

RegenMed Systems is a private U.S. medical device company focused on bone marrow harvesting technologies for regenerative medicine, transplantation, and related cell and gene therapy applications. Its lead product, MarrowMiner, is an FDA-cleared minimally invasive bone marrow harvest system designed to collect marrow and marrow-derived stem cells from a single entry site under local anesthesia. The company positions the device as an upstream enabling technology for bone marrow transplantation, orthopedic and regenerative medicine procedures, and potentially for future in vivo gene delivery. RegenMed also describes an emerging MarrowRx effort aimed at using intraosseous marrow access for gene and cell delivery, including work relevant to genetic and infectious diseases. The company appears to operate as a small private venture originating from Stanford Biodesign and licensed Stanford intellectual property.